What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Robert S. Kerbel spends much of his time researching Cancer research, Angiogenesis, Immunology, Internal medicine and Chemotherapy.
Robert S. Kerbel combines subjects such as Cell culture, Cell growth, Tyrosine kinase, Tumor progression and Kinase with his study of Cancer research.
Robert S. Kerbel interconnects Vascular endothelial growth factor A, Vascular endothelial growth factor, Endothelial stem cell and Receptor tyrosine kinase in the investigation of issues within Angiogenesis.
Robert S. Kerbel has researched Immunology in several fields, including In vitro, Bioinformatics, Progenitor cell, Stem cell and Phenotype.
His Internal medicine study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Endocrinology and Oncology.
His Chemotherapy research integrates issues from Cancer and Pharmacology.
His most cited work include:
- Angiogenesis as a therapeutic target (2164 citations)
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (1471 citations)
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (1471 citations)
What are the main themes of his work throughout his whole career to date?
Robert S. Kerbel mostly deals with Cancer research, Internal medicine, Cancer, Angiogenesis and Immunology.
His research integrates issues of Cell culture, Metastasis, Chemotherapy and Tumor progression in his study of Cancer research.
His work deals with themes such as Tumor microenvironment and Regimen, which intersect with Chemotherapy.
His Internal medicine study incorporates themes from Endocrinology and Oncology.
His Angiogenesis research includes themes of Endothelial stem cell, Vascular endothelial growth factor A, Vascular endothelial growth factor and Blood vessel.
His Immunology research includes elements of Phenotype, Drug resistance and Progenitor cell.
He most often published in these fields:
- Cancer research (61.26%)
- Internal medicine (33.98%)
- Cancer (29.00%)
What were the highlights of his more recent work (between 2012-2020)?
- Internal medicine (33.98%)
- Cancer (29.00%)
- Cancer research (61.26%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cancer, Cancer research, Oncology and Breast cancer.
He usually deals with Internal medicine and limits it to topics linked to Melanoma and Disseminated disease and Brain metastasis.
His study looks at the relationship between Cancer and topics such as Pharmacology, which overlap with Camptothecin, Toxicity, Drug resistance, Intensive care medicine and Low-dose chemotherapy.
His Cancer research research is mostly focused on the topic Angiogenesis.
His work carried out in the field of Oncology brings together such families of science as Clinical trial, Bevacizumab, Chemotherapy, Adjuvant therapy and Metronomic Chemotherapy.
His work deals with themes such as Regimen, Colorectal cancer, Primary tumor and Immunology, which intersect with Breast cancer.
Between 2012 and 2020, his most popular works were:
- Antiangiogenic therapy in oncology: current status and future directions. (393 citations)
- Consensus guidelines for the use and interpretation of angiogenesis assays (194 citations)
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa. (145 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Pharmacology, Cancer, Cancer research, Internal medicine and Oncology.
His Pharmacology research includes themes of Bevacizumab, Chemotherapy, Metastatic breast cancer, Toxicity and Drug resistance.
The study incorporates disciplines such as Disease progression and Pathology in addition to Cancer.
Robert S. Kerbel specializes in Cancer research, namely Neovascularization.
His Oncology study integrates concerns from other disciplines, such as Colorectal cancer and Melanoma.
His study in Metastasis is interdisciplinary in nature, drawing from both Blood vessel and Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
